ea0059oc1.6 | Translational highlights | SFEBES2018
Altieri Barbara
, Herterich Sabine
, Sbiera Silviu
, Volante Marco
, Francia Silvia De
, Casa Silvia Della
, Pontecorvi Alfredo
, Quinkler Marcus
, Kienitz Tina
, Mannelli Massimo
, Canu Letizia
, Chortis Vasileios
, Kaltsas Gregory
, Kroiss Matthias
, Terzolo Massimo
, Fassnacht Martin
, Ronchi Cristina L
Adrenocortical carcinoma (ACC) is a rare tumor with poor prognosis and the only approved drug for advanced disease is mitotane. The cytochromes P450 (CYP) 2W1 and 2B6 are proposed predicting markers of sensitivity to mitotane treatment. Aim of the study was to evaluate the relationship between CYP2W1 and/or CYP2B6 polymorphisms and response to mitotane in ACC.Methods: We performed a multicentric retrospective study including 182 ACC patients (F/M=121/61)...